切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2017, Vol. 06 ›› Issue (02) : 58 -63. doi: 10.3877/cma.j.issn.2095-3216.2017.02.003

所属专题: 文献

论著

狼疮肾炎肾小管间质损伤的临床特点及其对预后的影响
张岩1, 蔡广研1,(), 刘述文1, 张雪光1, 寇佳1, 陈仆1, 吴杰1, 孟金铃1, 尹忠1, 张利1, 陈香美1   
  1. 1. 100853 北京,解放军总医院肾脏病科、解放军肾脏病研究所、肾脏疾病国家重点实验室、国家慢性肾病临床医学研究中心
  • 收稿日期:2016-10-28 出版日期:2017-04-28
  • 通信作者: 蔡广研

Clinical characteristics of tubulointerstitial lesions and their impacts on prognosis of lupus nephritis

Yan Zhang1, Guangyan Cai1,(), Shuwen Liu1, Xueguang Zhang1, Jia Kou1, Pu Chen1, Jie Wu1, Jinling Meng1, Zhong Yin1, Li Zhang1, Xiangmei Chen1   

  1. 1. Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing 100853, China
  • Received:2016-10-28 Published:2017-04-28
  • Corresponding author: Guangyan Cai
  • About author:
    Corresponding author: Cai Guangyan, Email:
引用本文:

张岩, 蔡广研, 刘述文, 张雪光, 寇佳, 陈仆, 吴杰, 孟金铃, 尹忠, 张利, 陈香美. 狼疮肾炎肾小管间质损伤的临床特点及其对预后的影响[J/OL]. 中华肾病研究电子杂志, 2017, 06(02): 58-63.

Yan Zhang, Guangyan Cai, Shuwen Liu, Xueguang Zhang, Jia Kou, Pu Chen, Jie Wu, Jinling Meng, Zhong Yin, Li Zhang, Xiangmei Chen. Clinical characteristics of tubulointerstitial lesions and their impacts on prognosis of lupus nephritis[J/OL]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2017, 06(02): 58-63.

目的

了解狼疮肾炎肾小管间质损伤的临床特点及其对预后的影响。

方法

收集1990年1月1日至2011年6月30日在解放军总医院肾脏病科经肾活检确诊为狼疮肾炎的309例患者的临床及病理资料,所有患者均符合1997年美国风湿病学会推荐的系统性红斑狼疮(SLE)分类标准。采用2003年国际肾脏病协会及肾脏病理学会修订的狼疮肾炎病理分型标准对所有患者进行重新病理分型。计算该组狼疮肾炎肾间质炎细胞浸润、肾小管萎缩、间质纤维化、肾小管上皮细胞变性的发生率;采用秩和检验分析不同类型狼疮肾炎之间肾小管间质损伤的差异及发生病理转型的Ⅳ型狼疮肾炎转型前后肾小管间质损伤的差异。采用Kaplan-Meier曲线分析肾小管间质损伤对狼疮肾炎预后的影响。

结果

①本组狼疮肾炎病例中肾间质出现炎细胞浸润、肾小管萎缩、间质纤维化、肾小管上皮细胞变性的比例分别为86.5%,66.5%,66.9%和55.1%。②不同类型的狼疮肾炎其间质炎细胞浸润、肾小管萎缩、间质纤维化程及肾小管上皮细胞变性程度不同(均P﹤0.05);其中,Ⅲ型和Ⅳ型狼疮肾炎患者肾小管间质损伤较重(χ2=13.857, P<0.001)。本组病例中有47例IV型狼疮肾炎患者行重复肾活检,其中有14例在第二次肾活检时转为Ⅱ型(29.7%),但其重复肾活检时间质炎细胞浸润、肾小管萎缩、间质纤维化及肾小管上皮细胞变性程度与转型前比较差异无统计学意义(均P>0.05)。③间质炎细胞浸润、肾小管萎缩及间质纤维化可影响患者的预后,病变越重,预后越差(均P﹤0.001);而各种程度的肾小管上皮细胞变性对患者预后无影响(P=0.07)。

结论

狼疮肾炎肾小管间质损伤发生率高,不同类型的狼疮肾炎的肾小管间质病变程度不同。肾小管间质损伤程度不影响IV型狼疮肾炎的病理转型,且病理转型前后肾小管间质损害改变不明显。肾小管间质损伤可影响患者的预后,损伤越重预后越差。

Objective

To investigate the clinical characteristics of tubulointerstitial lesions (TIL) and their impacts on prognosis of lupus nephritis.

Methods

Three hundred and nine patients with lupus nephrits from the Department of Nephrology, Chinese PLA General Hospital, were confirmed by renal biopsy. Clinical and pathological parameters of this cohort were collected. All patients were reviewed and reclassified according to the 2003 Classification System of International Society of Nephrology (ISN)/Renal Pathology Society (RPS). Semiquantitative score was used to assess the severity of renal injury. Kaplan-Meier curve was used to analyze the outcomes of patients with different TIL.

Results

The percentages of interstitial inflammatory cells infiltration, tubular atrophy, interstitial fibrosis, and tubular epithelial cell degeneration were 86.5%, 66.5%, 66.9%, and 55.1%, respectively. Class Ⅱ, Ⅲ, Ⅳ, and Ⅴ lupus nephritis were different from each other in the interstitial inflammatory cells infiltration, tubular atrophy, interstitial fibrosis, and tubular epithelial cell degeneration (all P<0.05). The severity of TIL in class Ⅲ and Ⅳ lupus nephritis were more severe than those in class Ⅱ and Ⅴ (χ2 =13.857, P﹤0.001). 47 patients with class Ⅳ lupus nephritis received repeat-biopsies, among whom 14 cases transformed to class Ⅱ, but the differences in interstitial inflammatory cells infiltration, tubular atrophy, interstitial fibrosis, and tubular epithelial cell degeneration were not significant (all P>0.05). The interstitial inflammatory cells infiltration, tubular atrophy, and interstitial fibrosis were associated with the patients′ prognosis: the more severe TILs, the poorer prognosis (all P<0.001).

Conclusions

The incidence of TILs in lupus nephritis was high. TILs in different classes of lupus nephritis were different from each other. The degree of TILs did not affect the pathological transformation of class IV lupus nephritis, and the changes of TILs before and after pathological transformation were not obvious. TILs may predict the renal outcomes: the more severe TILs, the poorer prognosis.

表1 309例狼疮肾炎患者临床特征及病理数据
表2 各型狼疮肾炎小管间质损伤评分比较(±s)
图1 各型狼疮肾炎肾小管间质病变程度分布
表3 狼疮肾炎Ⅳ型两次肾活检相关指标的比较(±s)
表4 狼疮肾炎肾小管间质不同病变对肾脏预后的影响
图2 狼疮肾炎患者肾小管间质不同病变对肾脏预后的影响
[1]
Jeruc J, Jurcic V, Vizjak A, et al. Tubulo-interstitial involvement in lupus nephritis with emphasis on pathogenesis [J]. Wien Klin Wochenschr, 2000, 112(15-16): 702-706.
[2]
Hill GS, Delahousse M. Proteinuria and tubulointerstitial lesions in lupus nephritis [J]. Kidney Int, 2001, 60(5): 1893-903.
[3]
Seshan SV, Jennette JC. Renal disease in systemic lupus erythematosus with emphasis on classification of lupus glomerulonephritis [J]. Arch Pathol Lab Med, 2009, 133(2): 233-248.
[4]
Gao J, Cai G, Liu S, et al. Characteristics and in uence factors of pathologic transformation in the subclasses of class IV lupus nephritis [J]. Rheumatol Int, 2012, 32(6): 1751-1759.
[5]
Weening JJ, D′Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemeic lupus erythematosus revisited [J]. J Am Soc Nephrol, 2004, 15(2): 241-250.
[6]
O′Dell JR, Hays RC, Guggenheim SJ, et al. Tubulointerstitial renal disease in systemic lupus erythematosus [J]. Arch Intern Med, 1985, 145(11): 1996-1999.
[7]
Yu F, Wu L, Tan Y, et al. Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system [J]. Kidney Int, 2010, 77(9): 820-829.
[8]
Austin HA III, Mueni LR, Joyce KM, et al. Diffuse proliferative lupus nephritis: Identification of specific pathologic features affecting renal outcome [J]. Kidney Int, 1984, 25(4): 689-695.
[9]
Wei CH, Ho YS, Chou BL, et al. Lupus nephritis, emphasizing tubulointerstitial lesions: a clinico-pathological analysis [J]. Zhonghua Yi Xue Za Zhi (Taipei), 1993, 51(1): 27-32.
[10]
Austin HA 3rd, Muenz LR, Joyce M, et al. Prognostic factors in lupus nephritis [J]. Am J Med, 1983, 75(3): 382-391.
[11]
Hill GS, Delahousse M, Nochy D, et al. Class IV-S versus class IV-G lupus nephritis: Clinical and morphologic differences suggesting different pathogenesis [J]. Kidney Int, 2005, 68(5): 2288-2297.
[12]
Aruga S, Horiuchi T, Shou I, et al. Relationship between renal anemia and prognostic stages of IgA nephropathy [J]. J Clin Lab Anal, 2005, 19(2): 80-83.
[13]
Zappitelli M, Duffy CM, Bernard C, et al. Evaluation of activity, chronicity and tubulointerstitial indices for childhood lupus nephritis [J]. Pediatr Nephrol, 2008, 23(1): 83-91.
[14]
Tsuruta Y, Uchida K, Itabashi M, et al. Antiphospholipid antibodies and renal outcomes in patients with lupus nephritis [J]. Inter Med, 2009, 48(21): 1875-1880.
[15]
Park MH, D′Agati V, Appel GB, et al. Tubulointerstitial renal disease in nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis [J]. Nephron, 1986, 44(4): 309-319.
[16]
Hsieh C, Chang A. Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring [J]. Arthritis Care Res (Hoboken), 2011, 63(6): 865-874.
[17]
Omokawa A, Wakui H, Okuyama S, et al. Predominant tubulointerstitial nephritis in a patient with systemic lupus erythematosus: phenotype of infiltrating cells [J]. Clin Nephrol, 2008, 69(6): 436-444.
[18]
Ajay K, Singh MB. Predominant tubulointerstitial lupus nephritis [J]. Am J Kidney Dis, 1996, 27(2): 273-278.
[19]
Chang A, Henderson S, Liu N, et al. In-situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis [J]. J Immunol, 2011, 186(3): 1849-1860.
[20]
Steinmetz O, Velden J, Kneissler U, et al. Analysis and classification of B cell infiltrates in lupus and ANCA-associated nephritis [J]. Kidney Int, 2008, 74(4): 448-457.
[1] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[2] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[3] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[4] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[5] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[6] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[7] 李伟, 宋子健, 赖衍成, 周睿, 吴涵, 邓龙昕, 陈锐. 人工智能应用于前列腺癌患者预后预测的研究现状及展望[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 541-546.
[8] 关小玲, 周文营, 陈洪平. PTAAR在乙肝相关慢加急性肝衰竭患者短期预后中的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 841-845.
[9] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[10] 陈晓鹏, 王佳妮, 练庆海, 杨九妹. 肝细胞癌VOPP1表达及其与预后的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 876-882.
[11] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[12] 刘郁, 段绍斌, 丁志翔, 史志涛. miR-34a-5p 在结肠癌患者的表达及其与临床特征及预后的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 485-490.
[13] 陈倩倩, 袁晨, 刘基, 尹婷婷. 多层螺旋CT 参数、癌胚抗原、错配修复基因及病理指标对结直肠癌预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 507-511.
[14] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
[15] 郭曌蓉, 王歆光, 刘毅强, 何英剑, 王立泽, 杨飏, 汪星, 曹威, 谷重山, 范铁, 李金锋, 范照青. 不同亚型乳腺叶状肿瘤的临床病理特征及预后危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 524-532.
阅读次数
全文


摘要